Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as "isoglycaemic" glucose without numerically changing the incretin effect in patients with type 2 diabetes

被引:0
|
作者
Foley, J. E. [1 ]
Becker, L. [2 ]
Koethe, L. [2 ]
Dejager, S. [3 ]
Schweizer, A. [4 ]
Nauck, M. A. [2 ]
机构
[1] Novartis, E Hanover, NJ USA
[2] Diabet Zentrum, Bad Lauterberg Im Harz, Germany
[3] Novartis, Paris, France
[4] Novartis, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
917
引用
收藏
页码:S367 / S367
页数:1
相关论文
共 50 条
  • [31] Effect of dpp-4 inhibitors therapy on left atrial volume index in patients with type 2 diabetes
    Papazafiropoulou, A.
    Trikkalinou, A.
    Tountas, C.
    Theodosis-Georgilas, A.
    Markakis, V.
    Ioannidis, C.
    Bampali, V.
    Petropoulou, K.
    Foussas, S.
    Melidonis, A.
    DIABETOLOGIA, 2016, 59 : S533 - S533
  • [32] Degree of DPP-4 inhibition after sitagliptin treatment estimated from intact and total GLP-1 and GIP responses to oral glucose in patients with type 2 diabetes
    Vardarli, I.
    Arndt, E.
    Deacon, C. F.
    Holst, J. J.
    Koethe, L. D.
    Baranov, O.
    Nauck, M. A.
    DIABETOLOGIA, 2012, 55 : S109 - S110
  • [33] Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study
    Kim, Young-Gun
    Byun, JungHyun
    Yoon, Dukyong
    Jeon, Ja Young
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Park, Rae Woong
    Kim, Hae Jin
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [34] Macroalgal protein hydrolysates from Palmaria palmata influence the 'incretin effect' in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion
    McLaughlin, C. M.
    Harnedy-Rothwell, P. A.
    Lafferty, R. A.
    Sharkey, S.
    Parthsarathy, V.
    Allsopp, P. J.
    McSorley, E. M.
    FitzGerald, R. J.
    O'Harte, F. P. M.
    EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (08) : 4439 - 4452
  • [35] Macroalgal protein hydrolysates from Palmaria palmata influence the ‘incretin effect’ in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion
    C. M. McLaughlin
    P. A. Harnedy-Rothwell
    R. A. Lafferty
    S. Sharkey
    V. Parthsarathy
    P. J. Allsopp
    E. M. McSorley
    R. J. FitzGerald
    F. P. M. O’Harte
    European Journal of Nutrition, 2021, 60 : 4439 - 4452
  • [36] A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin
    Hiroshi Nomoto
    Hideaki Miyoshi
    Hajime Sugawara
    Kota Ono
    Shingo Yanagiya
    Mayuko Oita
    Akinobu Nakamura
    Tatsuya Atsumi
    Diabetology & Metabolic Syndrome, 9
  • [37] A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin
    Nomoto, Hiroshi
    Miyoshi, Hideaki
    Sugawara, Hajime
    Ono, Kota
    Yanagiya, Shingo
    Oita, Mayuko
    Nakamura, Akinobu
    Atsumi, Tatsuya
    DIABETOLOGY & METABOLIC SYNDROME, 2017, 9
  • [38] Insulin Response to a Standardized Meal Improved in Well Controlled Type 2 Diabetes Patients
    Yahaya, Norhayati
    Kyi, Win Mar
    Noor, Norhayati Mohd
    Bebakar, Wan Mohamed Wan
    INTERNATIONAL MEDICAL JOURNAL, 2012, 19 (02): : 109 - 111
  • [39] DPP-4 Inhibitor Teneligliptin Improves Insulin Resistance and Serum Lipid Profile in Japanese Patients with Type 2 Diabetes
    Kusunoki, M.
    Sato, D.
    Nakamura, T.
    Oshida, Y.
    Tsutsui, H.
    Natsume, Y.
    Tsutsumi, K.
    Miyata, T.
    DRUG RESEARCH, 2015, 65 (10) : 532 - 534
  • [40] The effect of DPP-4 inhibitors therapy on the left atrial volume index in patients with type 2 diabetes mellitus
    Papazafiropoulou, A. K.
    Trikkalinou, A.
    Ganotopoulou, A.
    Kasinos, N.
    Ioannidis, C.
    Tountas, C.
    Foussas, S.
    Melidonis, A.
    ARCHIVES OF HELLENIC MEDICINE, 2016, 33 (05): : 708 - +